Pharmacy and Medications

FDA Announces Rule Prohibiting Sale of Dietary Supplements Containing Ephedrine Alkaloids

ATTENTION: Dietary supplements containing Ephedrine Alkaloids (may be sold as Ephedra or Ma Huang) was removed from the US market on April 12, 2004 due to potentially fatal safety concerns.

FDA RECOMMENDATION: Avoid consumption of products containing Ephedrine Alkaloids (may be sold as Ephedra or Ma Huang) as they pose an unreasonable risk to health.

For additional information about this withdrawal, please follow the link below:FDA Announces Rule Prohibiting Sale of Dietary Supplements Containing Ephedrine Alkaloids

For more information:

Go to the Pharmacy and Medications health topic, where you can:

Read articles on this topic
Browse the previously asked questions

This article is a NetWellness exclusive.

Last Reviewed: Feb 04, 2011

David Baker, PharmD, DABAT
Formerly, Clinical Assistant Professor of Pharmacy
College of Medicine
The Ohio State University